Searchable abstracts of presentations at key conferences in endocrinology

ea0019p148 | Diabetes, Metabolism and Cardiovascular | SFEBES2009

Extreme hypertriglyceridaemia, the therapeutic use of insulin

Naziat A , Chandran S , Ali A

We present a case of a 44-year-old chef, presenting with a fortnightÂ’s history of a pruritic rash over his trunk and axillae. He was diagnosed to have hypertension, which was treated by lifestyle interventions. His diet was poor, and he drank 40 units of alcohol per week. His parents had hypercholesterolemia, but there was no history of premature coronary artery disease. On examination, his BMI was 31.62 kg/m2, and he had eruptive xanthomata on his chest, abdom...

ea0037ep1018 | Thyroid (non-cancer) | ECE2015

Adiponectin and gut hormones in thyroid dysfunction: a new concept (PFG axis)

Emami S Ali , Hedayati Mehdi , Nazem M Reza

Background: Integration between fat tissue, gastrointestinal tract, and the brain has attracted scientific interest in recent years. Thyroid hormones influence carbohydrate mechanisms via its interaction with adipocytokines and gut hormones. Adiponectin, ghrelin and obestatin play important roles in metabolism regulation. TSH receptors have been reported to be present in adipose tissue. Moreover, gut peptides signal to their functional cogna...

ea0044p212 | Reproduction | SFEBES2016

Gonadotrophin secretion is a useful adjunct in the diagnosis of patients with hyperprolactinaemia

Clarke S , Abbara A , Nesbitt A , Ali S , Comninos AN , Hatfield E , Martin NM , Sam A , Meeran K , Dhillo W

Background: Hyperprolactinaemia accounts for 1 in 7 patients presenting with amenorrhoea. Recent data suggests that prolactin acts at the hypothalamus to reduce GnRH-pulsatility. Conditions in which GnRH-pulsatility is reduced, such as hypothalamic amenorrhoea, favour FSH over LH secretion from the pituitary gland. We examined gonadotrophin secretion in hyperprolactinaemic patients as a surrogate marker of GnRH-pulsatility.Methods: A retrospective analys...

ea0019p355 | Thyroid | SFEBES2009

Variable dosage radio-iodine regimes for the treatment of hyperthyroidism: analysis of outcome and its implications in treatment planning

Comninos A , Ali S , Pontello L , Danga A , Darko D , McHardy-Young S

Introduction: The treatment of hyperthyroidism is complex. Radio-iodine administration remains the definitive option despite debate regarding optimum dosage and strategy.Method: Thyroid status in all patients receiving first dose radio-iodine over a 5 year period was reviewed at 3, 6, 12 and (most at) 24 months. Radio-iodine doses were individualised depending on thyroid gland size, co-morbidities and patient choice. The objective was euthyroidism with h...

ea0007p70 | Diabetes, metabolism and cardiovascular | BES2004

The metabolic syndrome is common in type 2 but uncommon in type 1 diabetes mellitus

Al-Saraj F , McDermott J , McAteer S , Ali M , Tormey W , Sreenan S

Studies in the general population have shown a prevalence of the metabolic syndrome of 17-25%. We have studied the prevalence of the metabolic syndrome in patients with diabetes mellitus (DM). A total of 150 consecutive patients with type 1 (21%) or type 2 DM (79%), mean age 59.1y (28-85), attending for annual review were studied to determine if they satisfy (ATP III) diagnostic criteria for the metabolic syndrome. Fasting plasma glucose, triglycerides, HDL cholesterol, blood ...

ea0050p284 | Neuroendocrinology and Pituitary | SFEBES2017

Non-functioning pituitary macroadenomas: characteristics and outcomes following endoscopic trans-sphenoidal surgery – a single UK tertiary referral centre experience

Seejore Khyatisha , Alavi S Ali , Pearson Sam Matthew , Robins James MW , Tyagi Atul , Nix Paul , Wilson Tom , Phillips Nick , Orme Stephen M , Murray Robert D

Background: Non-functioning pituitary adenomas (NFPA) account for 30-35% of pituitary adenomas. They can lead to hypopituitarism and visual field defects. Trans-sphenoidal resection of pituitary adenoma remains the treatment of choice.Methods: We compared clinical, biochemical, and imaging characteristics of NFPAs at presentation with post-surgical outcomes in a retrospective cohort study. Patients who underwent end...

ea0050p284 | Neuroendocrinology and Pituitary | SFEBES2017

Non-functioning pituitary macroadenomas: characteristics and outcomes following endoscopic trans-sphenoidal surgery – a single UK tertiary referral centre experience

Seejore Khyatisha , Alavi S Ali , Pearson Sam Matthew , Robins James MW , Tyagi Atul , Nix Paul , Wilson Tom , Phillips Nick , Orme Stephen M , Murray Robert D

Background: Non-functioning pituitary adenomas (NFPA) account for 30-35% of pituitary adenomas. They can lead to hypopituitarism and visual field defects. Trans-sphenoidal resection of pituitary adenoma remains the treatment of choice.Methods: We compared clinical, biochemical, and imaging characteristics of NFPAs at presentation with post-surgical outcomes in a retrospective cohort study. Patients who underwent end...